Ivo Timmermans
Pleco Therapeutics receives FDA Orphan Drug Designation
January 16, 2024 11:30 ET | Pleco Therapeutics B.V.
The U.S Food and Drug Administration (FDA) has granted Orphan Drug Designation to Pleco Therapeutics BV’s lead compound, PTX-252 for the treatment of AML.
finacialnews-logo-final-01 (2).png
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024 10:25 ET | FN Media Group LLC
PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the...
Largest study to dat
Largest study to date of high-dose methotrexate associated acute kidney injury supports the use of Voraxaze® (glucarpidase)
December 11, 2023 09:51 ET | BTG Specialty Pharmaceuticals
West Conshohocken, PA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announces the presentation of the largest study to date of patients with high-dose methotrexate (HDMTX)...
United States Liver Cancer Therapeutics Research Report 2023: Markets, Competition, Forecast and Opportunities, 2018-2028
December 07, 2023 11:08 ET | Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "United States Liver Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
Emergen logo.png
Chronic Lymphocytic Leukemia Market Size Worth USD 21.22 Bn in 2032 | Emergen Research
December 05, 2023 09:17 ET | Emergen Research
Vancouver, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The global chronic lymphocytic leukemia (CLL) market, valued at USD 10.00 Billion in 2022, is poised for substantial growth with a projected revenue...
Research Nester Logo.jpg
Pancreatic Cancer Market revenue to reach USD 36 Billion by 2036, says Research Nester
November 29, 2023 05:30 ET | Research Nester
New York, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The global pancreatic cancer market size is slated to expand at ~18% CAGR between 2024 and 2036. The market is poised to garner a revenue of USD 36...
Derm-Biome Pharmaceuticals Announces Collaboration with Massachusetts General Hospital in Skin Cancer Study
November 28, 2023 10:00 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver based biopharmaceutical company with a focus on skin disease, is excited to announce that...
MesoPher as a Maintenance Treatment after Chemotherapy, 2023 Research Report: Drug Insights and Market Forecasts, 2019-2032 - Focus on 7 Major Markets
November 23, 2023 11:13 ET | Research and Markets
Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "MesoPher Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Research Nester Logo.jpg
Germ Cell Tumor Market revenue to hit USD 122 Billion by 2035, says Research Nester
November 21, 2023 06:30 ET | Research Nester
New York, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global germ cell tumor market size is projected to grow at a CAGR of over 12% from 2024-2036. The market is expected to garner a revenue of USD 122...
LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations
November 13, 2023 08:30 ET | Lixte Biotechnology Holdings, Inc.
PASADENA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a new...